Draft:Zosurabalpin
Submission declined on 4 January 2024 by Umakant Bhalerao (talk). This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|
- Comment: In addition to the reviewer's comments, I would also suggest you to dive into the guidelines at WP:DRUGGUIDE, which should help you learn how to structure the draft appropriately. Oltrepier (talk) 20:16, 4 January 2024 (UTC)
- Comment: Please see WP:CITE for assistance on citing references.-- Umakant Bhalerao (talk) 12:09, 4 January 2024 (UTC)
Zosurabalpin is a new antibiotic class that works against multidrug-resistant bacteria. First results have been published in January 2024.
Morgan K. Gugger & Paul J. Hergenrother "A new type of antibiotic targets a drug-resistant bacterium", nature, 03 January 2024, https://www.nature.com/articles/d41586-023-03988-2
Claudia Zampaloni, Patrizio Mattei, et al. "A novel antibiotic class targeting the lipopolysaccharide transporter", nature, 03 January 2024, https://www.nature.com/articles/s41586-023-06873-0
Linda Geddes "Scientists hail new antibiotic that can kill drug-resistant bacteria", The Guardian, 03 January 2024, https://www.theguardian.com/science/2024/jan/03/scientists-new-class-antibiotic-kill-drug-resistant-bacteria